Features of the immunohistochemical diagnostics of neuroendocrine tumors.
DOI:
https://doi.org/10.26641/1997-9665.2015.4.66-71Keywords:
NET, immunohistochemistry, CK 7Abstract
Background. The possibility of neuroendocrine tumor (NET) development from almost any organ causes problems in determination of a true primary site after detection of such metastases in lymph nodes or liver. It impels to consider the expression of immunohistochemical organ-specific markers such as cytokeratin (СК) along with the morphological characteristics. Objective. Determine the immunophenotype of neuroendocrine tumors of different localizations. Methods. Material from 52 patients (30 women and 22 men) aged 31 to 79 years (median 57 years) had been retrospectively analyzed during Jan 2012 – Oct 2014. Material included NET of different localization (9 cases in stomach, 7 in lung, 5 in colon, 3 in small intestine, 3 in larynx, 3 in mammary gland, 2 in pancreas, 1 in cervix and 1 in uterus body) or its metastasis from an unknown primary site (12 in lymph nodes, and 6 in the liver). СК Рan (clone AE1/AE3), Chromogranin A (CHR A) (clone LK2H10), Synaptophysin (SYN) (clone SYP02), CD95 (clone АВ3), CK 7 (clone OV-TL 12/30), Vimentin (VIM) (clone V9) were used as a primary monoclonal antibodies. Results. 96% of cases have turned out to be CK Рan+, except 2 (3.8%) NET with a localization in lymph nodes. 84.6 % of tumors expressed SYN, except 2 (22.2%) in stomach, 1 (14.3%) in lung, 1 (100%) in uterus body, 3 (25%) in lymph node and 1 (16.7%) in liver metastasis. 82.7% gave a positive staining for CHR A, except for 3 (60%) in colon, 1 (33.3%) in small intestine, 1 (11,1% ) in stomach , 3 (25 %) in lymph nodes metastases (both of which are NET with СК Рan-) and 1 (16.7%) of liver metastases. VIM+ were only 4 cases (both of which are NET, 1 (100% ) of uterus body and 1 (16.7% ) of liver metastasis). Positive cases of CK 7 expression were 6 (66.7%) in stomach NET (all carcinoids), 3 (42.9%) in lung, 1 (20%) in colon, 1 (33.3%) in larynx, 2 (16.7%) in lymph node and 2 (33.3%) in liver metastasis. Conclusions. The most common NET phenotype of these localizations is CK Рan+, CHR A+ and/or SYN+, CD95+, VIM-. Expression of CK 7 is intermittent and can not be used to reliably determine the primary site of NET.
References
- Petrov SV, Reikhlin NT editors: [Manual on immunohistochemical diagnostics of human tumors]. 4th ed. Kazan: Title; 2012. 623 p. Russian.
- Fletcher CDM, author. Diagnostic histopathology of tumors. 4th ed. PA: Elsevier; 2013. 1148 p.
- Wong HH, Chu P. Wong Hannah H. Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol. 2012; 3(3): 262-84.
- Namikawa T, Oki T, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation. Med Mol Morphol. 2013 Mar;46(1):34-40. doi: 10.1007/s00795-012-0006-8.
- Ishida M, Sekine S, Fukagawa T, Ohashi M, Morita S, Taniguchi H, Katai H, Tsuda H, Kushima R. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis. Am J Surg Pathol. 2013 Jul;37(7):949-59. doi: 10.1097/PAS.0b013e31828ff59d.
- Wachter DL, Hartmann A, Beckmann MW, Fasching PA, Hein A, Bayer CM, Agaimy A. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma. Biomed Res Int 2014 19;2014:408459.
- Bosman FT, Carneiro F, Hruban RH, Theise ND, authors. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. 417 p.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Morphologia
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
